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Abstract
Objective—Src family kinases (SFK) have been implicated in regulating growth factor and 
integrin-induced proliferation, migration, and gene expression in multiple cell types. However, 
little is known about the role of these kinases in the growth, homing, and engraftment potential of 
hematopoietic stem and progenitor cells.
Results—Here we show that loss of hematopoietic-specific SFKs Hck, Fgr, and Lyn results in 
increased number of Sca-1+Lin− cells in the bone marrow, which respond differentially to 
cytokine-induced growth in vitro and manifest a significant defect in the long-term repopulating 
potential in vivo. Interestingly, a significant increase in expression of adhesion molecules, known 
to coincide with the homing potential of wild-type bone marrow cells is also observed on the 
surface of SFK−/− cells, although, this increase did not affect the homing potential of more 
primitive Lin−Sca-1+ SFK−/− cells. The stem cell–repopulating defect observed in mice 
transplanted with SFK−/− bone marrow cells is due to the loss of Lyn Src kinase, because 
deficiency of Lyn, but not Hck or Fgr, recapitulated the long-term stem cell defect observed in 
mice transplanted with SFK−/− bone marrow cells.
Conclusions—Taken together, our results demonstrate an essential role for Lyn kinase in 
positively regulating the long-term and multilineage engraftment of stem cells, which is distinct 
from its role in mature B cells and myeloid cells.
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Engraftment and reconstitution of normal hematopoiesis following transplantation of 
hematopoietic stem/progenitor (HSC/P) cells is the product of several important parameters, 
including the ability of hematopoietic stem cells (HSC) to home to, anchor within, and 
survive in specialized bone marrow (BM) niches, followed by timely proliferation and self-
renewal of stem cells for life-long hematopoiesis. While investigators have sought to 
understand the mechanisms behind each individual step, engraftment remains largely 
undefined.
Besides homing and anchoring of HSC/P cells following transplantation, signals emanating 
from cytokine receptors also play a prominent role in regulating HSC/P cell growth and 
survival. In general, both positive and negative signals induced in response to cytokine 
stimulation contribute to this process. Deregulated signaling downstream from cytokine 
receptors can alter the growth and differentiation of these cells and, in some cases, 
contribute to leukemogenesis. Examples of molecules that are activated in response to 
hematopoietic growth factors include, but are not limited to, nonreceptor tyrosine kinases, 
such as Src family kinases (SFKs). SFKs function in signal transduction from growth factor 
receptors for granulocyte macrophage colony-stimulating factor (GM-CSF), interleukin 
(IL)-3, IL-5, stem cell factor (SCF), erythropoietin, M-CSF, G-CSF, thrombopoietin, and 
Flt3 [1–16]. Although diverse cytokine receptors activate SFKs in response to ligand 
binding, most of the data thus far has been derived by studying cell-line models using 
dominant negative and activating approaches. Thus, the physiologic relevance of SFK 
activation in primary HSC/Ps is poorly understood.
Among the known Src family kinases, Lyn, Hck, and Fgr are expressed exclusively in the 
hematopoietic compartment [17]. Unique functions for SFKs have been identified by 
conducting experiments in mice lacking the expression of each one of these family members 
[17]. However, the phenotypes of these mice are often subtle due to functional redundancy 
between individual family members. For example, it is still not fully clear the extent to 
which Hck regulates myeloid cell functions, as the phenotype of Hck−/− mice was limited to 
a mild defect in Fc receptor–independent phagocytic activity of macrophages. Mutant mice 
of Src kinases lacking more than one family member have suggested a broader as well as a 
redundant role for Hck and Fgr family members in regulating myeloid cell functions [17]. In 
contrast, deficiency of Lyn alone affects both positive and negative aspects of receptor 
signaling in myeloid and lymphoid cells [18]. Lyn−/− mice are hyperresponsive to myeloid 
growth factors and develop a myeloproliferative disorder due, in part, to loss of negative 
regulation through SHP-1 and SHIP phosphatases [19]. The importance of regulating Lyn 
activation is further demonstrated by additional pathological changes that occur in Lyn-
deficient mice, including lethal antibody-mediated autoimmune disease [20–23]. Lyn-
deficient mice succumb to autoimmune disease, and B cells from Lyn-deficient mice 
demonstrate hypersensitivity to B-cell receptor (BCR) stimulation. In the B-cell 
compartment, in addition to positively contributing to BCR-induced ty-rosine 
phosphorylation, Lyn also plays an essential nonredundant role in phosphorylating specific 
tyrosine residues present in the immunoreceptor tyrosine-based inhibitory motifs in the 
cytoplasmic domains of inhibitory receptors, such as CD22 [24,25] and FcγRIIB [22,26].
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Based on these studies, it is clear that Lyn plays an essential role in regulating signals via 
several cytokine and antigen receptors in mature myeloid progenitors as well as in B cells; it 
is, however, not known how deficiency of Lyn impacts long-term repopulating ability of 
stem cells in a myeloablated host. Furthermore, it is not known how well the stem/
progenitors cells from Lyn-deficient mice compete with normal wild-type (WT) BM cells in 
a competitive repopulation assay and whether there is redundancy and/or specificity between 
the functions of other hematopoietic-specific Src family kinases, such as Hck and Fgr, in 
regard to regulating long-term repopulating ability of stem cells. Given the involvement of 
Src kinases in regulating the trafficking and growth of nonhematopoietic cells as well as of 
more mature hematopoietic cells, including macrophages, neutrophils, and B cells, we 
initiated the present study to determine the involvement of hematopoietic-specific Src 
kinases Hck, Fgr, and Lyn in homing and long-term engraftment of BM cells following 
myeloablative transplantation. Our results show that loss of hematopoietic-specific SFKs 
Hck, Fgr, and Lyn results in increased number of Sca-1+Lin− cells in the BM, which 
respond differently to different cytokine stimuli in vitro and show a significant defect in the 
long-term repopulating potential in vivo. Interestingly, BM cells from SFK−/− mice show a 
significant increase in expression of adhesion molecules, known to coincide with the homing 
potential of WT BM cells, however, this increase does not affect the homing potential of 
SFK−/− Lin−Sca-1+ cells. The stem cell–repopulating defect observed in mice transplanted 
with SFK−/− BM cells appears to be due to the loss of Lyn, because only the deficiency of 
Lyn, but not Hck or Fgr, recapitulates long-term stem cell defect observed in mice 
transplanted with SFK−/− BM cells. Our results reveal an essential role for Lyn kinase in 
positively regulating long-term and multilineage engraftment of stem cells.
Materials and methods
Mice
Mice lacking various members of hematopoietic-specific SFKs (Hck, Fgr, and Lyn) have 
been backcrossed into C57BL/6 strain (CD45.2 allele) for more than 20 generations [27,28]. 
Mice lacking the expression of different combinations of the three hematopoietic-specific 
Src kinases have been generated and used in these studies: Lyn−/−, Fgr−/−, Hck−/−, and 
Lyn/Fgr/Hck−/− (SFK−/−). “SFK knockout” (SFK KO) will be used hereafter to collectively 
refer to all these different genotypes, while “SFK−/−” will be used to refer to Lyn/Fgr/
Hck−/−. Congenic C57BL/6 (CD45.2 allele) and B6.BoyJ mice (CD45.1 allele) were 
purchased from Jackson Laboratories (Bar Harbor, ME, USA) and maintained in our animal 
facility and used between 8 to 12 weeks of age. The Indiana University School of Medicine 
Institutional Animal Care and Use Committee approved all studies.
Flow-cytometric analysis
Low-density BM cells (LDBM) from the different SFK KO mice were stained with CD45.2- 
fluorescein isothiocyanate (FITC), Sca-1–phycoerythrin (PE), and one of the following 
antibodies to analyze adhesion molecule phenotype: CD43-biotin (clone S7), CD49D-biotin 
(clone 9C10), CD49e-biotin (clone 5H10-27; MFR5), or CD62L-biotin (clone MEL-14). 
Biotinylated antibodies were developed with streptavidin-allophycocyanin (APC) 
(Molecular Probes, Eugene, OR, USA). Harvested BM and spleen from recipients of SFK 
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KO cells in homing studies were stained with CD45.2-FITC and CD45.1-PE to determine 
chimerism, and then separately with CD45.2-FITC, Sca-1-PE, and anti-adhesion molecule 
antibodies as described here. All antibodies were from BD Pharmingen (San Diego, CA, 
USA). Cells were analyzed using a FACSCalibur (Becton Dickinson Immunocytometry 
Systems [BDIS], San Jose, CA, USA).
Harvesting and purification of Lin− BM cells
BM cells were flushed from the tibias and femurs of SFK KO mice, WT, and B6.BoyJ mice 
using Iscove’s modified Dulbecco’s media (Invitrogen, Carlsbad, CA, USA) containing 5% 
fetal calf serum (FCS; Hyclone Laboratories, Logan, UT, USA). LDBM cells were prepared 
by centrifugation on Ficoll-Hypaque (density, 1.119; Sigma, St Louis, MO, USA). B6.BoyJ 
LDBM cells were used as competitor cells for all competitive repopulation experiments. 
Lyn−/−, Hck−/−, Fgr−/−, and SFK−/− LDBM cells were used as test cells in at least two 
independent experiments.
Lineage depletion was performed using the Easy Sep procedure from Stem Cell 
Technologies (Vancouver, BC, Canada). Briefly, LDBM cells were stained with biotinylated 
anti-mouse monoclonal antibodies specific for mature cell lineage antigens CD45R (B220, 
clone RA3-6B2), Gr-1 (Ly-6G, clone RB6-8C5), CD4 (L3T4, clone RM4-5), CD8a (Ly-2, 
clone 53-6.7), Ter119 and Mac-1 (CD11b, clone M1/70) (all purchased from Pharmingen) at 
a concentration of 1 uL per 106 cells. Cells were incubated at 4°C for 20 minutes and 
washed once with 10-fold excess of buffer, per manufacturer’s recommendation. Thereafter, 
cells were resuspended and incubated with EasySep mouse biotin selection cocktail (Stem 
Cell Technologies) at a concentration of 1.0 uL per 106 cells for 15 minutes at 4°C. Next, 
magnetic nanoparticles were added at a concentration of 0.5 uL per 106 cells for 10 minutes 
at 25°C and cells were subjected to a magnet three more times. Lineage-depleted cells were 
stained with APC rat anti-mouse CD117 (c-Kit) and PE-conjugated rat anti-mouse Sca-1 
(both from Pharmingen). Negative controls were stained with PE-conjugated IgG2a and 
FITC-conjugated IGg2b. Based on these controls, Lin−c-Kit+Sca-1+ cells were isolated with 
a fluorescence-activated cell sorted (FACStar Plus, BDIS) under sterile conditions. Purity of 
Lin−Sca-1+c-Kit+ cells was >99%.
Competitive repopulation experiments
Ten to 12-week-old mice were lethally irradiated (1100-cGy split dose) before 
transplantation as described previously [29,30]. Limiting dilutions of LDBM (1 × 105 to 3 × 
105) or c-Kit+Sca-1+Lin− cells (1000 to 10,000) from WT, Hck−/−, Fgr−/−, Lyn−/−, and 
SFK−/− mice were mixed with a constant number of B6. BoyJ LDBM cells (1 × 105). Each 
cell mixture was resuspended in 0.5 mL Iscove’s modified Dulbecco’s media 2% FCS and 
injected into the tail vein of lethally irradiated (950 cGy administered in a single dose from 
a 137Cs γ-rradiator [Gamma Cell 40; Nordion International, Kanata, Ontario, Canada]) 
recipients.
Chimerism analysis by fluorescence cytometry
Tail vein blood samples (100 uL) were obtained monthly post-transplantation for analysis of 
donor cell chimerism and multiline-age analysis. Peripheral blood cells were incubated in 
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red blood cell lysis buffer for 5 minutes at 4°C. Cells were washed twice, resuspended in 
phosphate-buffered saline 0.1% bovine serum albumin, and aliquoted into eight individual 
tubes for antibody staining. Each sample was stained with CD45.2-FITC (C57BL/6) and 
CD45.1-PE (B6.BoyJ strain) plus four individual lineage markers conjugated to PE/APC at 
4°C for 20 minutes. Samples were washed twice and resuspended in phosphate-buffered 
saline 0.1% bovine serum albumin before analysis by fluorescence cytometry. All data were 
analyzed using CELL Quest software (BDIS).
Homing studies
The ability of different SFK KO HSC/Ps to home to the BM and spleen following 
intravenous infusion was analyzed in short-term tracking studies as described previously 
[30]. Grafts consisted of LDBM cells, or purified Sca-1+Lin− (CD3−, B220−, Gr-1−) and 
Sca-1+Lin+ (CD3+, B220+, Gr-1+) cells isolated by flow-cytometric cell sorting using Sca-1-
FITC and lineage antibodies in APC. Sca-1+Lin− and Sca-1+Lin+ cells were used as grafts to 
compare the homing of two BM populations with opposing levels of hematopoietic 
potential. Briefly, 17.5 × 106 to 20 × 106 LDBM cells or 0.14 × 106 to 0.16 × 106 
Sca-1+Lin− and Sca-1+Lin+ cells, isolated from WT C57/BL6 or SFK−/− mice (CD45.2 
allele) were injected into lethally irradiated B6.SJL-ptrca Pep3b/BoyJ (B6.BoyJ) mice 
(CD45.1 allele) 1 hour to 4 hours after radiation. Recipients were sacrificed 16 to 19 hours 
later, and single-cell suspensions from BM and spleen were lysed and analyzed for recovery 
of HSC/Ps.
Calculation of recovery of primitive donor cells
Frequency of donor cells falling within a light scatter gate including lymphocytes and large 
granular cells was determined for each harvested tissue based on the background 
fluorescence of cells from unmanipulated mice. Frequencies were multiplied by the total 
number of cells in each tissue, and then divided by the number of cells in the original graft 
to calculate the recovery of transplanted cells. For LDBM transplants only, frequency of 
Sca-1+ cells among donor cells was also determined and used in conjunction with tissue 
cellularity to calculate recovery of Sca-1+ cells.
Results
Primitive phenotype of SFK KO cells
To begin to understand the HSC/P cell phenotype of the different SFK KO cells, we first 
characterized the BM phenotype of SFK KO cells by examining the expression of Sca-1, 
lineage markers, c-Kit, and a pattern of adhesion molecules known to be expressed on 
murine long-term engrafting cells, specifically CD43+ CD49+ CD62L− [29]. Figure 1A 
depicts the percentage of Sca-1+ cells in SFK−/− BM, which is significantly less than WT 
BM cells, whereas no differences were found for the other Src kinase mutants. Because 
overall BM cellularity was similar (data not shown), absolute number of SFK−/− BM Sca-1+ 
cells was also decreased compared to WT. Despite low numbers of Sca-1+ cells in SFK−/− 
mice, the fraction of these cells that exhibited a primitive phenotype (Lin-, c-Kit+, CD43+, 
CD49e+, CD62L−) was significantly increased in SFK−/− mice, as well as in Lyn−/− mice 
(Figs. 1B to 1F) compared to WT BM cells. These results suggest that deficiency of three 
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Src kinases collectively or of Lyn kinase alone results in increased numbers of cells with an 
immunophenotype known to be enriched in long-term repopulating cells.
SFK−/− BM cells differentially regulate the growth of progenitors in response to cytokines
Previous studies have shown that multiple hematopoietic cytokines use Src kinases for 
growth and survival, however, most of these studies have been conducted in cell lines 
utilizing dominant negative and/or activated versions of Src kinases. Because we observed 
an increase in the number of BM progenitors with a primitive immunophenotype in SFK−/− 
mice, we next assessed the growth potential of SFK−/− BM cells in response to various 
cytokines. As seen in Figure 2A, a significant increase in the number of colony-forming 
units in culture (CFU-C) is observed in SFK−/− BM cells when grown in the presence of G-
CSF. In contrast, CFU-C generation in the presence of IL-3, SCF, or a combination of five 
different cytokines, including SCF, erythropoietin, G-CSF, IL-3, and thrombopoietin was 
significantly reduced in these same cells compared to control cells. GM-CSF stimulation 
showed no significant difference in colony formation in any group under these conditions. 
Consistent with the reduced clonogenic potential of SFK−/− BM cells in the presence of 
IL-3, SCF, and the combination of five cytokines, the clonogenic potential of phenotypically 
defined KIT+ Lin-Sca-1+ (KLS) SFK−/− BM cells was also significantly reduced compared 
to WT controls (74 ± 12 [WT] vs 29 ± 12 [SFK−/−], n = 4, *p <0.05). Likewise, a significant 
reduction in the generation of high proliferative potential CFCs was also noted in SFK−/− 
KLS cells (27 ± 8 [WT] vs 9 ± 3 [SFK−/−], n = 3, *p < 0.05). Consistently, thymidine 
incorporation assay utilizing the same population of SFK−/− cells also revealed a significant 
reduction in thymidine uptake in SFK−/− KLS cells compared to WT controls (42,099 ± 
4709 [counts per minute] WT vs 16176 ± 1469 [counts per minute] SFK−/−, *p < 0.05). To 
further explore the clonogenic potential of SFK−/− BM cells to G-CSF and GM-CSF, we 
conducted additional experiments in the presence of a range of cytokine concentrations. As 
shown in Figure 2B, G-CSF stimulation of SFK−/− BM cells at all concentrations tested 
gave rise to significantly more CFU-Cs. In contrast, GM-CSF stimulation of these same cell 
groups resulted in either similar number of CFU-Cs or reduced CFU-Cs at lower 
concentrations. We also examined the growth potential of SFK−/− BM cells to M-CSF and 
found a significant increase in colony formation compared to control cells (Fig. 2B). Taken 
together, these results suggest that deficiency of SFKs differentially regulates the growth of 
BM hematopoietic progenitors.
Competitive repopulating ability of SFK−/− HSC/Ps compared to WT controls
Given the differential response of SFK−/− BM cells to cytokines and the presence of 
increased numbers of relatively primitive progenitors in the BM of SFK−/− mice, we 
examined the long-term repopulating potential of SFK−/− BM cells. To this end, SFK−/− and 
WT cells were assayed in a competitive repopulation assay using three different test to 
competitor cell ratios. Regardless of whether LDBM or KLS cells were used as test cells, 
SFK−/− cells consistently exhibited reduced chimerism compared to WT cells 6 months 
posttransplantation (Fig. 3A and C). To determine if this effect is sustained upon secondary 
transplantation and at the level of stem cells, marrow of mice transplanted with either the 
WT or SFK−/− LDBM cells (Fig. 3A) at a test to competitor ratio of 1:3 were harvested 6 
months post primary transplantation, and 1 × 106 LDBM donor cells were injected to 
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lethally irradiated secondary recipients. As shown in Figure 3B, the reduced chimerism was 
apparent in secondary recipients 6 months posttransplantation. These results suggest that 
loss of SFKs in BM cells impairs the long-term repopulating ability of stem cells. Consistent 
with the enhanced CFU-C generation observed in the presence of G-CSF and M-CSF in 
vitro, a lineage bias towards the generation of Gr-1/Mac-1–positive cells was observed in 
mice transplanted with SFK−/− BM cells compared to controls in both primary and 
secondary recipients (data not shown).
Homing properties of SFK−/− cells
We next assessed whether the reduced repopulating ability of SFK−/− stem cells was due in 
part to reduced homing of these cells to the marrow. To do this, we investigated whether 
Hck, Fgr, and Lyn are important in trafficking of HSC/P cells to the BM following 
intravenous transplantation. LDBM grafts of the various Src mutants were prepared and 
transplanted into lethally irradiated syngeneic recipients. Sixteen to 19 hours later, recovery 
of total cells and primitive phenotypes was determined in recipient BM and spleen. Figures 
4A and B show that total and Sca-1+ SFK−/− cells, respectively, homed in significantly 
higher numbers than WT to recipient BM. Interestingly, while the other SFK KO genotypes 
did not differ in homing to BM, Lyn−/− cells exhibited significantly poor homing to spleen 
(Figs. 4C and D).
Expression of adhesion molecules involved in primitive hematopoiesis was also examined 
on BM- and spleen-homed cells as an additional measure of primitive HSC/P homing. As 
shown in Figures 5A and D, expression of CD43 and CD49e was higher on BM- and spleen-
homed Lyn−/− and SFK−/− cells, suggesting that Lyn may be the predominant molecule 
involved in vivo trafficking of HSC/P cells.
Homing of purified Sca-1+Lin- and Sca-1+Lin+ cells
We have previously shown that purified phenotypically defined BM cells, known to be 
enriched for long-term engraftment potential (Sca-1+lin−CD62L− or Sca-1+lin−CD49e+), 
home more efficiently to BM than cells lacking such potential (Sca-1+lin−CD62L+ or 
Sca-1+lin−CD49e−), which segregate preferentially to the spleen [31]. This differential 
homing of HSC vs non-HSC illustrates some specificity of the homing process. To 
determine if a similar specificity of homing of primitive vs more mature SFK−/− HSC/Ps 
exist, Sca-1+Lin− and Sca-1+Lin+ cells were isolated from SFK−/− and WT BM and 
transplanted into lethally irradiated WT recipients. Sixteen to 19 hours later, recipients were 
sacrificed and BM and spleen examined for the presence of donor cells. Similar to our 
previously reported finding, recovery of WT Sca-1+Lin− cells was significantly higher in 
BM (Fig. 6A), whereas recovery of Sca-1+Lin+ cells tended to be higher in spleen (Fig. 6B). 
However, recovery of either phenotype from SFK−/− mice did not differ in BM or spleen 
(Figs. 6C and D), suggesting that, based on known phenotypic definitions of primitive 
HSC/Ps, specificity of homing does not exist for SFK−/− primitive HSC/Ps in a manner 
similar to that of WT cells.
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Lyn but not Fgr or Hck contributes to reduced repopulating potential of SFK−/− BM cells
To determine which of the three SFKs contribute to impaired repopulating ability of SFK−/− 
BM cells, we performed competitive repopulation assay using BM cells from individual 
knockouts of Lyn, Fgr, and Hck. These studies were done using equal number of competitor 
and marrow cells derived from each of the three single Src kinase mutants, Lyn, Hck, and 
Fgr. As seen in Figure 7A, no significant difference in the overall chimerism was observed 
in mice transplanted with HSC/P lacking Fgr or Hck compared to WT controls 4 months 
posttransplantation. In contrast, deficiency of Lyn kinase demonstrated a significant 
reduction in overall engraftment compared to WT controls. The decrease was observed in 
every lineage examined and was also apparent in secondary recipients (Fig. 7B, 8A/B). 
These results suggest that the reduced engraftment observed in SFK−/− primary and 
secondary recipients is likely contributed by the deficiency of Lyn Src kinase.
Discussion
Despite the involvement of multiple cytokines in regulating the activation of Src family 
kinases, including Lyn, Hck, and Fgr the role of these enzymes in modulating the growth, 
homing, and long-term engraftment of hematopoietic stem and progenitor cells is poorly 
understood. In this study, we have examined the role of SFKs in cytokine-mediated growth, 
homing, and long-term engraftment of HSC/Ps. We show increased numbers of 
phenotypically defined stem/progenitors in the BM of Lyn−/− and SFK−/− mice but not 
Hck−/− or Fgr−/− mice. The increase in the number of Sca-1+Lin− cells in these mice is 
associated with increased colony-forming ability in response to M-CSF and G-CSF, but 
reduced growth in response to IL-3, SCF, and a combination of five cytokines. Although the 
short-term homing potential of SFK−/− LDBM cells to the recipient BM is significantly 
enhanced compared to WT controls, the homing potential of Sca-1+Lin+ or Sca-1+Lin− 
SFK−/− cells is similar to that observed using WT Sca-1+Lin+ or Sca-1+Lin− cells, although 
the homing specificity of SFK−/− cells is lost. In contrast, we found that serial competitive 
repopulation with SFK−/− BM was deficient relative to WT BM, although defects observed 
in primary recipients were not augmented by secondary transplantation. Remarkably, the 
phenotypic defects associated with the deficiency of SFKs (i.e., Lyn, Hck, and Fgr) are due 
in large part to deficiency of Lyn Src kinase because loss of Lyn, but not Hck or Fgr, also 
manifests a similar stem cell defect as that seen in mice transplanted with SFK−/− BM cells.
Our results demonstrating the presence of fewer Sca-1+ cells, yet more primitive Sca-1+Lin− 
cells in the BM of SFK−/− mice, which posses reduced clonogenic and engrafting potential, 
but enhanced homing potential than their WT counterparts suggests that SFKs impact the 
function of different BM progenitors differently. Although the precise mechanism(s) by 
which SFKs impact these functions in the HSC/P compartment are unclear, previous studies 
have demonstrated that these kinases in addition to both positively and negatively regulating 
functions in the same cell type can also antagonize the function of each other. For example, 
significant evidence exists to suggest that in B cells, early responses to BCR cross-linking 
are altered in Lyn−/− mice, supporting a role for Lyn in the initiation of signaling via the 
BCR [20,21,23]. Intriguingly, Lyn-deficient B cells are also hyperresponsive to anti-IgM– 
induced proliferation and demonstrate enhanced activation of mitogen-activated protein 
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kinase and sustained calcium mobilization [21–23,26]. Hernandez-Hansen et al. [32] have 
shown that dysregulated signaling in Lyn-deficient mast cells is due in part to enhanced Fyn 
activation, and a recent study by Hong et al [33] suggested that the Src kinase Hck regulates 
mast cell activation by suppressing activation of Lyn. These results suggest that regulation 
of SFKs in HSC/Ps is likely to be complex and may depend on the stimulus and 
development stage of the cells under investigation. Thus, the functional consequences of 
SFK activation may be context-dependent. We believe that the complex functional outcomes 
observed in the various HSC/P compartments reported in this article are likely to be a result 
of complex modes of SFK regulation.
Previous studies using Lyn-deficient mice have shown Lyn to play an essential role in 
maintaining signaling thresholds in B cells [21,25,26], myeloid cells, including in mast cells 
[14,19,34–37]. Loss of Lyn results in reduced activation of phosphatases, such as SHIP, 
which results in hypersensitivity to cytokines [19,24,25]. In both B cells as well as mast 
cells, loss of Lyn results in hyperactivation of AKT and the mitogen-activated protein kinase 
extracellular signal-regulated kinase. In macrophages, loss of Lyn results in hypersensitivity 
to GM-CSF and M-CSF [19,34]. Previous studies have also shown that deficiency of Lyn in 
aged mice results in extramedullary hematopoiesis, as well as macrophage tumors in some 
cases [19,38]. Our studies reveal a positive role for Lyn in regulating long-term engraftment 
of stem cells. We show that loss of Lyn in primitive HSC/P cells results in reduced 
engraftment in both primary and secondary recipient mice. Although the mechanism by 
which loss of Lyn impacts stem cell engraftment is not known, this is likely to occur as a 
result of reduced responsiveness to cytokines as demonstrated by reduced colony-forming 
ability of SFK−/− BM cells as well as more primitive cells in both a methylcellulose assay as 
well as in a short-term liquid culture assay.
Reduced competitive repopulating potential of SFK−/− KLS fraction, despite a marked 
increase in the number of Lin−Sca-1+ cells in the BM of SFK−/− mice, suggests that the 
surface phenotype of BM cells may not necessarily reflect their function in vivo. It is 
conceivable that alterations in the BM microenvironment as a result of SFK deficiency may 
alter the phenotypic characteristics of BM cells. Our data demonstrating differences in the 
expression of various critical adhesion molecules known to be associated with the 
engraftment and homing potential of WT stem/progenitor cells clearly illustrates this point. 
Others have also reported a lack of correlation between phenotypic markers and function of 
stem cells in both mutant mice as well as upon perturbing normal steady-state hematopoiesis 
[39–43].
An alternate, but unlikely possibility to explain the increase in the number of relatively 
immature HSC/P cells in the BM of SFK−/− mice could be attributed to microenvironmental 
changes in these mice. The analysis of primitive cells derived from mice carrying deletion of 
genes in every tissue, such as the ones described in the present study, does not allow for 
assessment of cell intrinsic vs extrinsic contributions to HSC/P functions. Although SFKs, 
Hck, Fgr, and Lyn are hematopoietic-specific, we have previously demonstrated that loss of 
these kinases collectively results in a BM environment that is more proteolytic than that of 
their WT counterpart [4]. Although, these modest changes in the level of proteases in the 
BM of SFK−/− mice did not result in changes in the engraftment potential of WT BM cells 
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when transplanted into SFK−/− recipients, we cannot rule out the subtle effects of a 
proteolytic BM environment on the genesis of stem/progenitor cells or for the necessary 
support to maintain the function of these cells prior to transplantation. Generation of 
conditional knockout mice in which Src kinases are specifically deleted in the stem/
progenitor cell compartment should help us address this issue in the future.
Our results demonstrating a lack of homing defect either in whole BM or Lin−Sca-1+ 
SFK−/− or Lyn−/− cells are intriguing. Ptasznik et al. [44] recently demonstrated a 
biochemical interaction between CXCR4 and Lyn Src kinase in normal BM progenitors. 
They showed that CXCR4-dependent stimulation of Lyn kinase is associated with the 
activation of phosphatidylinositol 3 kinase and loss of Lyn Src kinase in BMLD cells (i.e., 
Lyn−/− BM cells) impairs stromal-derived factor-1–induced migration in vitro by as much as 
70% compared to control cells. Although in their studies, stromal-derived factor-1–mediated 
inhibition in migration was not complete; our in vivo short-term homing studies using both 
SFK−/− or Lyn−/− LDBM cells demonstrate enhanced recovery of these cells in the BM of 
lethally irradiated recipients. Furthermore, fractionation of SFK−/− LDBM cells into 
Sca-1+Lin+ and Sca-1+Lin− cells did not reveal significant differences in the homing 
potential of these cells compared to WT control cells. Thus, although in vitro migration of 
Lyn−/− LDBM cells in response to stromal-derived factor-1 has been shown to be altered, in 
vivo this alteration is not sufficient to affect the homing potential of SFK−/− or Lyn−/− BM 
cells under the experimental conditions employed in the present study [44]. In summary, our 
studies highlight an essential role for Src kinases in regulating cell-intrinsic growth and 
engraftment of HSC/P cells and provide new insight into cytokine signaling during 
hematopoiesis.
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Figure 1. 
Primitive phenotype of Src family kinase (SFK) knockout cells. Low-density bone marrow 
(LDBM) cells from SFK knockout mice were analyzed for percentage of Sca-1+ cells and 
markers known to be expressed on primitive hematopoietic cells. (A) Percentage of Sca-1+ 
cells within LDBM cells. Percentages of Sca-1+ cells lacking lineage markers (CD3, B220, 
Gr-1, B), or expressing KIT (C), CD43 (D), CD49e (E), or CD62L (F) are shown in the 
remaining graphs. Data are from individual mice in 3 to 11 separate experiments; mean is 
given by horizontal line. *p < 0.05 compared with wild-type (WT).
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Figure 2. 
Deficiency of Src family kinases (SFKs) in bone marrow (BM) cells results in different 
responses to cytokines. Low-density BM (LDBM) cells from wild-type (WT) or SFK−/− 
mice were harvested and subjected to methylcellulose assay. (A) 3 × 104 LDBM cells were 
grown in methylcellulose in the presence of granulocyte colony-stimulated factor (G-CSF; 
25 ng/mL), granulocyte macrophage colony-stimulating factor (GM-CSF; 50 ng/mL), 
interleukin (IL)-3 (10 ng/mL), stem cell factor (SCF; 50 ng/mL), or a combination of five 
cytokines (erythropoietin 2 U/mL, G-CSF, SCF, IL-3, and GM-CSF). Colony-forming units 
in culture (CFU-Cs) were scored 7 to 10 days later. Bars represent the mean number of 
CFU-Cs ± standard deviation (SD) at various doses and in the presence of different 
cytokines. *p < 0.05 compared with WT; **p < 0.05 compared with WT. (B) 1.5 × 104 
LDBM cells were grown in methyl-cellulose in the presence of indicated concentrations of 
G-CSF, GM-CSF, and M-CSF. CFU-Cs were scored 7 to 10 days later. Bars represent the 
mean number of CFU-Cs ± SD at the indicated doses in the presence of different cytokines. 
*p < 0.05 compared to WT.
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Figure 3. 
Deficiency of Src family kinase (SFK) results in impaired repopulating capacity in a 
competitive repopulation assay. Peripheral blood chimerism in mice transplanted with wild-
type (WT) or SFK−/− low-density bone marrow (LDBM) (A) or KIT+Lin−Sca-1+ cells (C) 
and 1 × 105 competitor cells. Mean chimerism for LDBM (A) and c-Kit+Lin−Sca-1+ (C) cell 
number transplanted was calculated for each genotype, and the data generated at 6 months 
after transplantation are summarized in bar graphs. Eight mice (four per genotype) were 
transplanted at each test cell concentration (three different concentrations were used: 1:1, 
1:2, and 1:3 for LDBM cells and two different concentrations were used for Kit+Lin−Sca-1+ 
cells (1000 and 10,000). Experiments using LDBM were repeated twice. A total of 32 mice 
were transplanted (16 per genotype). Shown are data from 1:1 ratio in LDBM and 10,000 
KIT+Lin–Sca-1+ cells. Mean ± standard deviation (SD), *p < 0.05 SFK−/− vs WT. (B) 
LDBM cells from lethally irradiated primary recipients transplanted with WT or SFK−/− BM 
that demonstrated the highest chimerism (1:3; competitor-to-test ratio) were harvested and 1 
× 106 cells were transplanted into lethally irradiated secondary hosts. Mean chimerism was 
calculated for each genotype and data generated at 6 months after secondary transplantation 
are summarized in bar graphs. BM from 2 independent WT and SFK−/− primary recipients 
were transplanted into 24 lethally irradiated (12 for each genotype) mice. Mean ± SD, *p < 
0.05, SFK−/− vs WT. KSL = KIT+Sca-1+Lin−.
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Figure 4. 
Percent recovery of transplanted Src family kinases (SFK) knockout cells in bone marrow 
(BM) and spleen. Irradiated wild-type (WT) mice received 17.5 × 106 to 20 × 106 low-
density BM cells isolated from Lyn−/−, Fgr−/−, Hck−/−, SFK−/−, or WT mice, sacrificed 16 to 
19 hours later, and percent recovery of total donor cells and donor Sca-1+ cells in harvested 
BM (A, B) and spleen (C, D) were calculated as described in Materials and Methods. Data 
represent percent recovery in individual mice in 3 to 11 separate experiments; mean is given 
by horizontal line. *p < 0.05 compared with WT.
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Figure 5. 
Frequency of CD43+ and CD49e+ cells among donor Sca-1+ cells homed to bone marrow 
(BM) or spleen after transplantation. Irradiated wild-type (WT) mice received 17.5 × 106 to 
20 × 106 low-density LDBM cells isolated from Lyn−/−, Fgr−/−, Hck−/−, Src family kinases 
(SFK)−/−, or wild-type (WT) mice, sacrificed 16 to 19 hours later, and expression of CD43 
and CD49e examined on donor Sca-1+ cells recovered in BM (A, B) and spleen (C, D). Data 
represent percentage of recovered donor Sca-1+ cells expressing CD43 or CD49e in 
individual mice in four to nine separate experiments; mean is given by horizontal line. *p < 
0.05 compared with WT.
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Figure 6. 
Percent recovery of transplanted Src family kinase (SFK)−/− or wild-type (WT) Sca-1+lin+ 
or Sca-1+lin− graft cells in bone marrow (BM) and spleen of WT recipients. Irradiated WT 
mice received 1.4 × 105 to 1.6 0 105 purified Sca-1+lin+ or Sca-1+lin− cells isolated from 
SFK−/− or WT mice, sacrificed 16 to 19 hours later, and percent recovery of total donor cells 
in harvested BM (A, C) and spleen (B, D) was calculated as described in Materials and 
Methods. Data represent % recovery in individual mice in four separate experiments (n = 6 
mice total); horizontal line represents mean. *p < 0.05 compared with WT.
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Figure 7. 
Competitive repopulating ability of hematopoietic stem/progenitor (HSC/P) cells lacking 
expression of Hck, Fgr, or Lyn. (A) Peripheral blood (PB) lineage chimerism in mice 
transplanted with wild-type (WT), Hck−/−, Lyn−/−, or Fgr−/− low-density bone marrow (BM) 
cells and 1 × 105 competitor cells. Mean chimerism for each genotype was calculated and 
the data generated at 4 months after transplantation are summarized in bar graphs. 
Experiments were repeated twice with four to five mice in each group. Shown are data from 
1:1 ratio. Mean ± standard deviation, *p < 0.05 WT vs Lyn−/−. (B) Representative dot blots 
indicating multilineage engraftment of WT and Lyn−/− stem cells into myeloid and 
lymphoid lineages. PB cells were stained with antibodies that recognize myeloid and 
lymphoid lineages. Shown are percentages of donor cells from a representative mouse 
engrafted with WT or Lyn−/− BM cells and competitors.
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Figure 8. 
Reduced engraftment of Lyn−/− stem cells in lethally irradiated secondary recipients. Bone 
marrow (BM) of wild-type (WT) or Lyn−/− primary recipients were harvested after 4 months 
of primary transplantation and 1 × 106 low-density BM (LDBM) cells were transplanted into 
lethally irradiated secondary hosts. (A) Shows the mean chimerism for each genotype after 
12 weeks post secondary transplantation. LDBM cells from a WT and Lyn−/− primary 
recipient were transplanted into four to five lethally irradiated secondary recipients. Mean ± 
SD, *p < 0.05, Lyn−/− vs WT. (B) Representative dot blots indicating myeloid and lymphoid 
lineage engraftment in secondary recipients. Shown are percentages of donor cells from a 
representative mouse engrafted with WT or Lyn−/− LDBM cells.
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